视力障碍-话题@MedSci

#视力障碍#

9篇内容 | 1379人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2196809, encodeId=0680219680989, content=<a href='/topic/show?id=000990686c8' target=_blank style='color:#2F92EE;'>#视力障碍#</a>, objectTitle=Lancet子刊：隐秘的视力敌人！印度成年人视力障碍和失明及相关危险因素的全国患病率分析, objectType=article, longId=820188, objectId=1baa8201887d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/267914-eye.jpg, objectUrl=/article/show_article.do?id=1baa8201887d, replyNumber=0, likeNumber=0, createdTime=2024-04-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1baa8201887d, moduleTitle=Lancet子刊：隐秘的视力敌人！印度成年人视力障碍和失明及相关危险因素的全国患病率分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1baa8201887d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1390206, encodeId=a54f1390206c2, content=<a href='/topic/show?id=000990686c8' target=_blank style='color:#2F92EE;'>#视力障碍#</a>, objectTitle=Lancet子刊：天呐！视力障碍居然还有可能罹患帕金森病！, objectType=article, longId=294342, objectId=468c294342f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=468c294342f4, replyNumber=0, likeNumber=100, createdTime=2022-01-21, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=468c294342f4, moduleTitle=Lancet子刊：天呐！视力障碍居然还有可能罹患帕金森病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=468c294342f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390205, encodeId=99191390205b2, content=<a href='/topic/show?id=000990686c8' target=_blank style='color:#2F92EE;'>#视力障碍#</a>, objectTitle=Lancet Global Health：果不其然，全球视力障碍的发生率都越来越高！, objectType=article, longId=204544, objectId=5b9a20454449, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b9a20454449, replyNumber=0, likeNumber=90, createdTime=2020-12-17, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b9a20454449, moduleTitle=Lancet Global Health：果不其然，全球视力障碍的发生率都越来越高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b9a20454449)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390204, encodeId=e4cf139020437, content=<a href='/topic/show?id=000990686c8' target=_blank style='color:#2F92EE;'>#视力障碍#</a>, objectTitle=到2050年，失明和严重视力障碍患者将翻倍！, objectType=article, longId=201967, objectId=487120196eab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=487120196eab, replyNumber=0, likeNumber=83, createdTime=2020-10-12, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=487120196eab, moduleTitle=到2050年，失明和严重视力障碍患者将翻倍！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=487120196eab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390203, encodeId=8c84139020337, content=<a href='/topic/show?id=000990686c8' target=_blank style='color:#2F92EE;'>#视力障碍#</a>, objectTitle=Retina：亚洲群体中兰尼单抗与维替泊芬光动力疗法对近视脉络膜新生血管造成的视力障碍的治疗效果比较, objectType=article, longId=149444, objectId=ee5e149444ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee5e149444ff, replyNumber=0, likeNumber=65, createdTime=2018-09-25, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee5e149444ff, moduleTitle=Retina：亚洲群体中兰尼单抗与维替泊芬光动力疗法对近视脉络膜新生血管造成的视力障碍的治疗效果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee5e149444ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390202, encodeId=d97413902027f, content=<a href='/topic/show?id=000990686c8' target=_blank style='color:#2F92EE;'>#视力障碍#</a>, objectTitle=英国将开展用光遗传技术治疗视力障碍试验, objectType=article, longId=127185, objectId=509912e18561, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=509912e18561, replyNumber=0, likeNumber=80, createdTime=2018-01-23, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=509912e18561, moduleTitle=英国将开展用光遗传技术治疗视力障碍试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=509912e18561)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390201, encodeId=b971139020107, content=<a href='/topic/show?id=000990686c8' target=_blank style='color:#2F92EE;'>#视力障碍#</a>, objectTitle=Eur J Ophthalmol：歌剧中的盲人和视力障碍, objectType=article, longId=123718, objectId=3e9b123e18bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e9b123e18bc, replyNumber=0, likeNumber=79, createdTime=2017-12-18, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e9b123e18bc, moduleTitle=Eur J Ophthalmol：歌剧中的盲人和视力障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e9b123e18bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390200, encodeId=05801390200fc, content=<a href='/topic/show?id=000990686c8' target=_blank style='color:#2F92EE;'>#视力障碍#</a>, objectTitle=Lancet Global Health：全球视力障碍及失明因素分析——1990-2020, objectType=article, longId=116072, objectId=39021160e211, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39021160e211, replyNumber=0, likeNumber=90, createdTime=2017-10-15, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39021160e211, moduleTitle=Lancet Global Health：全球视力障碍及失明因素分析——1990-2020, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39021160e211)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390199, encodeId=9f071390199d9, content=<a href='/topic/show?id=000990686c8' target=_blank style='color:#2F92EE;'>#视力障碍#</a>, objectTitle=JAMA Ophthalmol：增加视力筛查和早期干预可降低视力障碍患病率, objectType=article, longId=70771, objectId=a372e0771f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a372e0771f8, replyNumber=0, likeNumber=89, createdTime=2016-06-16, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a372e0771f8, moduleTitle=JAMA Ophthalmol：增加视力筛查和早期干预可降低视力障碍患病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a372e0771f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1390198, encodeId=63411390198e7, content=<a href='/topic/show?id=000990686c8' target=_blank style='color:#2F92EE;'>#视力障碍#</a>, objectTitle=BMJ：阶梯疗法为视力障碍老年人的抑郁或焦虑开启了新希望, objectType=article, longId=59360, objectId=0f2e593602f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f2e593602f, replyNumber=0, likeNumber=80, createdTime=2015-11-25, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f2e593602f, moduleTitle=BMJ：阶梯疗法为视力障碍老年人的抑郁或焦虑开启了新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f2e593602f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

视力障碍

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#视力障碍#

Lancet子刊：隐秘的视力敌人！印度成年人视力障碍和失明及相关危险因素的全国患病率分析

2024-04-03发表于上海

ms2186806800017884 (审核中...)

前往app查看评论内容

#视力障碍#

Lancet子刊：天呐！视力障碍居然还有可能罹患帕金森病！

2022-01-21

ms2186806800017884 (审核中...)

前往app查看评论内容

#视力障碍#

Lancet Global Health：果不其然，全球视力障碍的发生率都越来越高！

2020-12-17

ms2186806800017884 (审核中...)

前往app查看评论内容

#视力障碍#

到2050年，失明和严重视力障碍患者将翻倍！

2020-10-12

ms2186806800017884 (审核中...)

前往app查看评论内容

#视力障碍#

Retina：亚洲群体中兰尼单抗与维替泊芬光动力疗法对近视脉络膜新生血管造成的视力障碍的治疗效果比较

2018-09-25

ms2186806800017884 (审核中...)

前往app查看评论内容

#视力障碍#

英国将开展用光遗传技术治疗视力障碍试验

2018-01-23

ms2186806800017884 (审核中...)

前往app查看评论内容

#视力障碍#

Eur J Ophthalmol：歌剧中的盲人和视力障碍

2017-12-18

ms2186806800017884 (审核中...)

前往app查看评论内容

#视力障碍#

Lancet Global Health：全球视力障碍及失明因素分析——1990-2020

2017-10-15

ms2186806800017884 (审核中...)

前往app查看评论内容

#视力障碍#

JAMA Ophthalmol：增加视力筛查和早期干预可降低视力障碍患病率

2016-06-16

ms2186806800017884 (审核中...)

前往app查看评论内容

#视力障碍#

BMJ：阶梯疗法为视力障碍老年人的抑郁或焦虑开启了新希望

2015-11-25

科室
- - 订阅+
  - 更多科室
工具
服务